Clinical Trial Update: A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy

View source ↗

Summary

A completed clinical trial assessing whether stopping maintenance therapy for Cytomegalovirus Retinitis is safe after effective anti-HIV therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Retinitis
• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Retinitis, HIV Infections | Status: COMPLETED